GB1474749A - Pharmaceutical preparations based on cyproterone - Google Patents

Pharmaceutical preparations based on cyproterone

Info

Publication number
GB1474749A
GB1474749A GB3912274A GB3912274A GB1474749A GB 1474749 A GB1474749 A GB 1474749A GB 3912274 A GB3912274 A GB 3912274A GB 3912274 A GB3912274 A GB 3912274A GB 1474749 A GB1474749 A GB 1474749A
Authority
GB
United Kingdom
Prior art keywords
cyproterone
pharmaceutical preparations
preparations based
sept
admixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3912274A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of GB1474749A publication Critical patent/GB1474749A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1474749 Compositions containing cyproterone or its esters SCHERING AG 6 Sept 1974 [6 Sept 1973] 39122/74 Heading A5B Pharmaceutical preparation for use in the treatment of psychiatric disorders comprise cyproterone in admixture or conjunction with a pharmaceutically suitable carrier or a preparation in dosage unit form suitable for oral administration which is free from oestrogens which comprises a cyproterone ester in admixture or conjunction with a pharmaceutically suitable carrier.
GB3912274A 1973-09-06 1974-09-06 Pharmaceutical preparations based on cyproterone Expired GB1474749A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732345377 DE2345377A1 (en) 1973-09-06 1973-09-06 PHARMACEUTICAL PREPARATION I

Publications (1)

Publication Number Publication Date
GB1474749A true GB1474749A (en) 1977-05-25

Family

ID=5892031

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3912274A Expired GB1474749A (en) 1973-09-06 1974-09-06 Pharmaceutical preparations based on cyproterone

Country Status (3)

Country Link
US (1) US3895110A (en)
DE (1) DE2345377A1 (en)
GB (1) GB1474749A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2880276A1 (en) * 2005-01-05 2006-07-07 Lefebvre Dominique Caparros USE OF ANTI-ANDROGENES IN THE TREATMENT OF AGGRESSIVE OR IMPULSIVE BEHAVIORS INDUCED BY DISEASES OF THE CENTRAL NERVOUS SYSTEM

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165504A (en) * 1998-09-23 2000-12-26 Barr Laboratories, Inc. Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
US6613758B1 (en) 1999-04-02 2003-09-02 Barr Laboratories, Inc. Method for treating osteoporosis in castrated prostatic cancer patients
US20090093513A1 (en) * 2007-10-09 2009-04-09 Hamann Mark T Method to Use Compositions Having Antidepressant Anxiolytic and Other Neurological Activity and Compositions of Matter
BRPI0914024A2 (en) 2008-10-10 2015-11-03 Teva Womens Health Inc pharmaceutical dosage forms, packaging and use of cyproterone acetate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1158966B (en) * 1961-04-29 1963-12-12 Schering Ag Process for the preparation of 6-chloro-1,2ª‡-methylene-í¸-17ª‡-hydroxyprogesterone esters

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2880276A1 (en) * 2005-01-05 2006-07-07 Lefebvre Dominique Caparros USE OF ANTI-ANDROGENES IN THE TREATMENT OF AGGRESSIVE OR IMPULSIVE BEHAVIORS INDUCED BY DISEASES OF THE CENTRAL NERVOUS SYSTEM
WO2006072732A1 (en) * 2005-01-05 2006-07-13 Dominique Caparros-Lefebvre Use of cyproterone acetate for treating aggressive behaviours in patients suffering from dementia

Also Published As

Publication number Publication date
US3895110A (en) 1975-07-15
DE2345377A1 (en) 1975-03-20

Similar Documents

Publication Publication Date Title
ZA762920B (en) Novel pharmaceutical preparation adapted for oral administration
AU1578688A (en) Pharmaceutical composition, for oral administration, designed to attenuate the effects of beta-lactamines
FR2321892A1 (en) PHARMACEUTICAL PREPARATIONS FOR ORAL ADMINISTRATION CONTAINING NANDROLONE-17B ESTER AND NEW NANDROLONE-17B ESTERS
PH13807A (en) Oral pharmaceutical preparation of esters testasterone
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
AU449293B2 (en) New adenosine-5'carboxylic acid derivatives andthe preparation thereof
GB1474749A (en) Pharmaceutical preparations based on cyproterone
GB1457546A (en) Pharmaceutical preparations comprising cephalosporin derivatives
GB1483650A (en) Pharmaceutical preparations based on mesterolone
GB1488995A (en) Compositions containing anti-androgenic compounds
GB1141214A (en) New derivatives of proscillaridin a
GB1473574A (en) Sitosterol esters
GB1500300A (en) Pharmaceutical preparation for the treatment of circulatory disorders
ZA802389B (en) New derivative of 1 alpha,25-dihydroxy-cholecalciferol,process for preparing it,its use as a medicament and the pharmaceutical compositions containing it
JPS5215813A (en) Preparation of stable medicine including homopyrimidazole derivative for aural administration
GB1292496A (en) Dosage units of contraceptive preparations for human use
ES388316A1 (en) Aminoalkyl-ethanoanthracenes
GB1465771A (en) Pharmaceutical composition and use thereofd
GB1141702A (en) Therapeutic compositions
GB1294538A (en) Pharmaceutical compositions
GB1363801A (en) Peptides and their preparation
GB1176049A (en) N-Substituted Noratropinium Salts
GB1472086A (en) Pharmaceutical composition for treatment of liver diseases
GB1504646A (en) Acyl cyanoguanidines
AU455827B2 (en) Amino'acid ester derivatives of 2h-chromen-5 ol

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee